Saturday 17 October 2026
Export CUPR’s income statement to Excel — free account
Cuprina Holdings (Cayman) Limited
CUPR Healthcare Medical Instruments & Supplies
Cuprina Holdings (Cayman) Limited’s revenue for fiscal 2025 (year ended December 2025) was $38,800.00, up 9.30% from fiscal 2024.
1.90
0.05
−2.56%
Follow CUPR
Cuprina Holdings (Cayman) Limited (CUPR) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| FEMY Femasys Inc. compare | n/m |
| RVP Retractable Technologies, Inc. compare | n/m |
| LUCY Innovative Eyewear, Inc. compare | n/m |
| MLSS Milestone Scientific, Inc. compare | n/m |
| NXGL NexGel, Inc. compare | n/m |
| BNGO Bionano Genomics, Inc. compare | n/m |
| RGNT Regentis Biomaterials Ltd. compare | — |
| MHUAF Meihua International Medical Technologies Co., Ltd. compare | — |
| CUPR Cuprina Holdings (Cayman) Limited | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)